**Question:** Side effect of salmeterol is -

A. Increased heart rate
B. Dizziness
C. Chest pain
D. Exercise-induced bronchoconstriction

**Core Concept:** Salmeterol is a long-acting beta2-agonist bronchodilator used for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It works by binding to beta2-adrenergic receptors in the lungs, leading to relaxation of smooth muscle and bronchodilation.

**Why the Correct Answer is Right:** Salmeterol is a selective long-acting beta2-agonist, meaning it primarily activates beta2-adrenergic receptors, leading to bronchodilation and improved lung function. It is generally well-tolerated, but some potential side effects include:

- Increased heart rate (Option A): Salmeterol acts on beta2-adrenergic receptors in the heart, which can increase heart rate in some individuals.
- Dizziness (Option B): Salmeterol can cause transient cardiovascular effects, including increased heart rate and blood pressure, which may lead to dizziness in some patients.
- Chest pain (Option C): Although salmeterol is generally well-tolerated, chest pain can occur due to its effects on the cardiovascular system.
- Exercise-induced bronchoconstriction (Option D): Salmeterol is a long-acting bronchodilator, not a bronchoconstrictor. However, some patients may experience worsening of symptoms during exercise due to a phenomenon known as "rebound bronchoconstriction." This occurs when the bronchoconstrictor effects of short-acting beta2-agonists (e.g., salbutamol) wear off, leading to a temporary worsening of symptoms before the effects of salmeterol take effect.

**Why Each Wrong Option is Incorrect:**

- Chest pain is mentioned in Option C, but salmeterol itself does not cause chest pain directly. Instead, it contributes to the underlying condition causing chest pain (e.g., exercise-induced bronchoconstriction).
- Option D is incorrect because salmeterol is a long-acting bronchodilator, not a bronchoconstrictor. Although it may exacerbate symptoms in a patient with rebound bronchoconstriction, this is separate from the direct effects of salmeterol itself.

**Clinical Pearls:**

1. When prescribing beta-agonists, consider the potential for rebound bronchoconstriction. This may lead to worsening of symptoms before the long-acting beta2-agonist begins to work effectively.
2. Assess patients with asthma or COPD for signs of rebound bronchoconstriction (e.g., increased shortness of breath, wheezing, or chest tightness) before prescribing a beta2-agonist and monitoring for improvement.
3. Although salmeterol is generally well-tolerated, be aware of potential side effects like increased heart rate and blood pressure, which can lead to dizziness or palpitations in some patients. Monitor these patients closely for these effects.

**Explanation:**